跳至主要内容
临床试验/NCT05035121
NCT05035121已完成不适用

Effects of Milk or Soy Milk Combined With Mild Resistance Exercise on the Muscle Mass and Muscle Strength in Very Old Nursing Home Residents With Sarcopenia

Taipei Medical University1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2017年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
height in meters

研究概览

简要总结

The purpose of this study was determine whether milk or soy milk supplements combined with resistance exercise improved sarcopenia in the elderly. This study was randomized controlled trail that recruited elderly people ≧65 years old with sarcopenia in the nursing home of Taipei Veterans General Hospital Su-Ao and Yuanshan Branch from June 2017 to December, 2017. The participants were divided into three groups, such as control, milk supplement and soy milk supplement. The milk and soy milk groups provided 200 mL milk or soy milk two times per day. Moreover, all participants joined the resistance exercise training program, three times per week (30 min/time). After 12 weeks, the anthropometry, sarcopenia index, blood biochemical index, nutrition status index, inflammation index, insulin resistance index, and dietary intake were measured.

详细描述

The anthropometry data included body weight and body fat. The sarcopenia index included appendicular skeletal muscle mass index, calf circumferences, hand grip and gait speed. Moreover, blood biochemical index (liver function as ALT, kidney function as creatinine), nutrition status index (prealbumin, 25-hydroxyvitamin D) were also analyzed. The blood hsCRP level was as inflammation index and insulin resistance index included fasting blood sugar, insulin, HbA1c and HOMA-IR. The daily dietary intake were also recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
65 Years 至 99 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≧ 65 years old
  • No allergies to milk and soy milk
  • Sarcopenia cases (AWGS)
  • Active ability

排除标准

  • End-of-life patient or estimated death within six months
  • Last stage of cancer
  • Chronic kidney disease stage 4

结局指标

主要结局

height in meters

时间窗: baseline

Height was measured by height meter

Change from baseline appendicular skeletal muscle mass index at 12 weeks

时间窗: 12 weeks

The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

Change from baseline hand grip at 12 weeks

时间窗: 12 weeks

The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

appendicular skeletal muscle mass in kilograms

时间窗: baseline

The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

Change from baseline appendicular skeletal muscle mass at 6 weeks

时间窗: 6 weeks

The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

Change from baseline appendicular skeletal muscle mass at 12 weeks

时间窗: 12 weeks

The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

Change baseline weeks height at 6 weeks

时间窗: 6 weeks

Height was measured by height meter

Change from baseline height at 12 weeks

时间窗: 12 weeks

Height was measured by height meter

appendicular skeletal muscle mass index in kg/m^2

时间窗: baseline

The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

Change from baseline appendicular skeletal muscle mass index at 6 weeks

时间窗: 6 weeks

The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

calf circumferences in centimeter

时间窗: baseline

calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

Change from baseline hand grip at 6 weeks

时间窗: 6 weeks

The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

Change from baseline calf circumferences at 6 weeks

时间窗: 6 weeks

calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

Change from baseline calf circumferences at 12 weeks

时间窗: 12 weeks

calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

Change from baseline gait speed at 6 weeks

时间窗: 6 weeks

The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

hand grip in kilograms

时间窗: baseline

The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

gait speed in meter per second

时间窗: baseline

The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

Change from baseline gait speed at 12 weeks

时间窗: 12 weeks

The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

次要结局

  • Change from baseline blood alanine transaminase activity at 12 weeks(12 weeks)
  • Change from baseline blood creatinine level at 12 weeks(12 weeks)
  • blood prealbumin level in mg/dL(baseline)
  • blood alanine transaminase activity in U/L(baseline)
  • Change from baseline blood prealbumin level at 12 weeks(12 weeks)
  • Change from baseline blood insulin level at 12 weeks(12 weeks)
  • blood 25-hydroxyvitamin D level in ng/mL(baseline)
  • Change from baseline blood 25-hydroxyvitamin D level at 12 weeks(12 weeks)
  • High sensitive C-reactive protein in mg/dL(baseline)
  • blood creatinine level in mg/dL(baseline)
  • blood fasting blood sugar in mg/dL(baseline)
  • Change from baseline blood fasting blood sugar at 12 weeks(12 weeks)
  • blood insulin level in milli-international unit/L(baseline)
  • blood HbA1c in percentage(baseline)
  • Change from baseline blood HbA1c at 12 weeks(12 weeks)
  • Change from baseline High sensitive C-reactive protein at 12 weeks(12 weeks)
  • Homeostasis model assessment-insulin resistance index (HOMA-IR)(baseline)
  • Change from baseline homeostasis model assessment-insulin resistance index (HOMA-IR) at 12 weeks(12 weeks)
  • blood insulin-like growth factor 1 in mg/dL(baseline)
  • Change from baseline blood insulin-like growth factor 1 at 12 weeks(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiun-Rong Chen

Professor

Taipei Medical University

研究点 (1)

Loading locations...

相似试验